The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Intensity modulation of chemoimmunotherapy for late stages of liver carcinoma.
Baofa Yu
Employment or Leadership Position - Jinan Baofa Cancer Hospital (U)
ZhenLu Ma
Employment or Leadership Position - Taimei Boafa Cancer Hospital (U)
Changjiang Guan
No relevant relationships to disclose
Wei Han
No relevant relationships to disclose
Yebin Che
No relevant relationships to disclose
Qiang Fu
No relevant relationships to disclose